Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers
Clinical trial NCT05188469 · COMPLETED
Trial details
- NCT number
- NCT05188469
- Sponsor
- EyeGene Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2024-05-29
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.